Higher MAR was associated with higher 30-day mortality, and MAR was identified as an independent predictor of poor prognosis in HBV-DC. Furthermore, the predictive values between MAR and Model for End-Stage Liver Disease score are comparable. Conclusions: MAR could be potentially used as a ...
EDITORS, We greatly appreciate the comment of Debnath and Rathi1 regarding our recently published paper exploring the modification of body composition following TIPSS insertion in the context of severe portal hypertension related to cirrhosis.2 The presented results could have suggested an unexpected ...
Cirrhosis is the end complication of manyliverdiseases and is characterized by abnormal structure and function of the liver. The diseases that lead to cirrhosis do so because they injure and kill liver cells. The subsequent inflammation and repair that is associated with the dying liver cells cause...
The manifestations of cirrhosis are protean. Patients with cirrhosis may come to clinical attention in numerous ways: 1. Stigmata of chronic liver disease on physical examination (e.g., palmar erythema, spider telangiectasias) 2. Abnormal serum chemistry test results and hematologic indices (e.g....
Cirrhosis is defined histologically as a diffuse hepatic process characterized by fibrosis and conversion of the normal liver architecture into structurally abnormal nodules. The progression of liver injury to cirrhosis may occur over weeks to years. Signs and symptoms Some patients with cirrhosis are co...
Innate immune cells are an essential first line of defence against pathogens. Activation of liver macrophages (Kupffer cells) and resident mastocytes generate proinflammatory and vaso-permeating mediators that induce accumulation of neutrophils, lymphocytes, eosinophils and monocytes in the liver, and ...
Cirrhosis represents a significant global health challenge, characterized by high morbidity and mortality rates that severely impact human health. Timely and precise prognostic assessments of liver cirrhosis are crucial for improving patient outcomes and
Purpose of the study: Patients with HBV/HIV co-infection are at an increased risk of progression to hepatic cirrhosis and eventual liver-related death. Th... C Katusiime,A Kambugu - 《Journal of the International Aids Society》 被引量: 4发表: 2012年 加载更多来源...
Pharmacotherapy for Liver Cirrhosis and Its Complications Alberto E. Muñoz, Mariano Cartier & Ayelén B. Kisch 514 Accesses Abstract A broad group of physicians is still afraid of administering statins because of the myth of statin toxicity and frequent statin-related nocebo effects. However, ...
The sensitive indicators were screened out from the model group, and a noninvasive diagnostic model of liver cirrhosis was established by using random forest method, and then the efficacy of the diagnostic model was validated by using the patients in the validation group. Results (1)A total of...